Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain

Author: Rutten-van Mölken Maureen   Oostenbrink Jan   Miravitlles Marc   Monz Brigitta  

Publisher: Springer Publishing Company

ISSN: 1618-7598

Source: The European Journal of Health Economics, Vol.8, Iss.2, 2007-06, pp. : 123-135

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract